CASI icon

CASI Pharmaceuticals
CASI

Overview Fund Activity

24 hedge funds and large institutions have $3.29M invested in CASI Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 2 closing their positions.

Holders
24
Holders Change
–
Holders Change %
0%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
8
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$100K
2
TRCT
2
Tower Research Capital (TRC)
New York
$7K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$20K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$461K
5
WPA
5
West Paces Advisors
Georgia
$179

Top Sellers

1
Federated Hermes
1
Federated Hermes
Pennsylvania
$1.58M
2
Prudential Financial
2
Prudential Financial
New Jersey
$0
3
WSCM
3
Wellington Shields Capital Management
New York
$369K
4
Morgan Stanley
4
Morgan Stanley
New York
$3.48K
5
UBS Group
5
UBS Group
Switzerland
$2.55K
Name Market Value Shares Shares
Change 		Shares
Change %
Osaic Holdings
26
Osaic Holdings
Arizona
$0 200 – –
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$0 58 +40 +222%
1
2